Everolimus is Safe as a Second-/Third-Line Therapy in Pediatric Autoimmune Hepatitis

Autoimmune hepatitis (AIH) can lead to progressive fibrosis in patients refractory to conventional therapy with prednisolone and azathioprine. The use of mammalian target of rapamycin (mTOR) inhibitors has recently emerged in refractory AIH, but no data have been published about everolimus in pediat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jannone, Giulia, Scheers, Isabelle, Smets, Françoise, Stephenne, Xavier, M Sokal, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins, Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158283/
https://www.ncbi.nlm.nih.gov/pubmed/37168629
http://dx.doi.org/10.1097/PG9.0000000000000227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158283/
https://www.ncbi.nlm.nih.gov/pubmed/37168629
http://dx.doi.org/10.1097/PG9.0000000000000227

Ejemplares similares